PRACTICE Guidelines REGISTRATION PLATFORM
News MORE
  • 2023.0306

    The Development of Reporting Guideline of clinical Practice Guidelines in General Practice provides detailed guidance for the makers and writers of the general practice guidelines, which will further improve the reporting quality of the general practice guidelines, especially the Chinese general practice guidelines, and promote the application in general medical practice, thus finally improving the quality of primary medical care.

  • 2023.0220

    Professor Gordon Guyatt of McMaster University and Professor Victor Montori of the Mayo Clinic jointly published a paper in the British Medical Journal (BMJ) entitled: Guidelines should consider clinicians' time needed to treat on January 3, 2023.

  • 2022.1126

    IGEST is a generic tool for screening guidelines for any specialty, target population, and healthcare organization, but it is intended only as a screening tool, primarily for quickly assessing guideline quality and determining whether they can be adopted or adapted in other settings, and is not a substitute for some of the more complex guideline quality evaluation tools.

  • 2022.1031

    In July 2022, Jose F. Meneses-Echavez et al. from the Norwegian Institute of Public Health published an article in the Journal of Clinical Epidemiology entitled "Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations". The aim of this study was to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.

Register MORE
  • 2024.0523
    Infectious diseases pose a significant global health threat, affecting social stability and national security. An effective infectious disease surveillance and early warning system is a crucial component of public health security and is essential for preventing and controlling outbreaks. Currently, enhancing surveillance and early warning capabilities is central to advancing high-quality development in disease prevention and control. Against this backdrop, multidisciplinary experts in epidemiology, clinical medicine, disease prevention and control, data science, and computer science have drawn on years of practical experience and conducted extensive reviews of existing domestic and international research, guidelines, and other materials. After repeated rounds of expert discussions, they have developed a consensus on the construction of intelligent surveillance and early warning systems with multi-point triggers for infectious diseases. The main content of this consensus includes the definition of related concepts for intelligent early warning systems with multi-point triggers for infectious diseases, a framework for key technologies, sources of multi-channel early warning data, classification of early warning methods, intelligent early warning pathways with multi-point triggers, response to early warning signals, and evaluation of early warning effectiveness. The aim is to provide a reference for the key technologies and platform construction of intelligent early warning systems with multi-point triggers for infectious diseases.
  • 2024.0523
    Genital mycoplasma infection is a common clinical infection in departments such as gynecology, andrology, and urology. It is mainly caused by Ureaplasma urealyticum, Mycoplasma hominis, and Mycoplasma genitalium, causing discomfort such as urinary tract infections, vaginitis, cervicitis, and pelvic inflammatory disease. It has a certain impact on fertility and is a hot topic of clinical attention. The Reproductive Tract Infection Research Group of the Sexual Medicine Professional Committee of the Chinese Sexuality Society presided over the development of the Expert Consensus on the Diagnosis and Treatment of Genital Mycoplasma Infection, which was published in 2016 and effectively guided clinical diagnosis and treatment. With the progress of research both domestically and internationally in recent years, new clinical studies and drugs continue to emerge, and it is necessary to make new revisions. The Reproductive Tract Infection Research Group of the Sexual Medicine Professional Committee of the Chinese Sexuality Society, in collaboration with the Reproductive tract infectious diseases Collaboration Group of Gynecology and Obstetrics Branch of Chinese Medical Association, has revised the diagnostic and treatment principles and specific plans for genital mycoplasma infection in accordance with the guiding principles of China's development/revision of clinical diagnosis and treatment guidelines, international consensus development processes, and evidence level standards.
  • 2024.0523
    This guide is intended to formulate recommendations and protocols for prevention and treatment of Chemotherapy- and/or radiotherapy-induced nausea and vomiting in order to provide effective guidance for clinical practice. Cancer is a serious threat to human health and one of the leading causes of death in the world. chemotherapy and radiotherapy is the main treatment for cancer, but it is often difficult for cancer patients to adhere to it because of the side effects of chemotherapy and radiotherapy. Nausea and vomiting is one of the most common side effects caused by radiotherapy and chemotherapy. More and more clinical evidence suggests that acupuncture and moxibustion is an effective method for the prevention of Chemotherapy- and/or radiotherapy-induced nausea and vomiting.At present, The American Society of clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) guidelines for the prevention and treatment of Chemotherapy- and/or radiotherapy-induced nausea and vomiting all mention and recommend acupuncture. However, there is still a lack of specific guidance for clinical practice of acupuncture and moxibustion in the prevention and treatment of Chemotherapy- and/or radiotherapy-induced nausea and vomiting. Therefore, it is necessary to formulate clinical practice guidelines for the prevention and treatment of Chemotherapy- and/or radiotherapy-induced nausea and vomiting with acupuncture and moxibustion, put forward standardized programs for the prevention and treatment of Chemotherapy- and/or radiotherapy-induced nausea and vomiting with acupuncture and moxibustion, and further promote the standardization and globalization of acupuncture and moxibustion.
  • 2024.0522
    The guidelines for exercise prescription in chronic obstructive pulmonary disease (COPD) are intended to provide evidence-based support for healthcare professionals, sports science specialists, and researchers in China. These guidelines aim to enhance the application of exercise prescriptions for COPD in clinical practice, scientific research, and classroom teaching, thereby ensuring significant value in these areas.
Registration process and operational mode of a CPG registry